Americana Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.64M Buy
96,757
+11,520
+14% +$495K 0.1% 147
2026
Q1
$3.13M Buy
85,237
+14,430
+20% +$684K 0.08% 176
2025
Q4
$3.6M Buy
70,807
+12,464
+21% +$637K 0.1% 163
2025
Q3
$3.24M Buy
58,343
+1,053
+2% +$61.6K 0.1% 163
2025
Q2
$3.95M Sell
57,290
-419
-0.7% -$28.5K 0.14% 141
2025
Q1
$4.01M Buy
57,709
+2,609
+5% +$215K 0.16% 121
2024
Q4
$4.74M Buy
55,100
+3,169
+6% +$343K 0.19% 110
2024
Q3
$6.18M Buy
51,931
+2,563
+5% +$342K 0.42% 68
2024
Q2
$7.05M Buy
49,368
+1,657
+3% +$220K 0.55% 46
2024
Q1
$6.13M Buy
47,711
+1,360
+3% +$162K 0.51% 55
2023
Q4
$4.79M Sell
46,351
-4,871
-10% -$482K 0.46% 63
2023
Q3
$4.68M Buy
51,222
+15,438
+43% +$1.36M 0.51% 51
2023
Q2
$2.9M Buy
35,784
+182
+0.5% +$14.9K 0.37% 72
2023
Q1
$2.83M Sell
35,602
-2
-0% -$142 0.45% 67
2022
Q4
$2.4M Sell
35,604
-298
-0.8% -$17.5K 0.42% 65
2022
Q3
$1.79M Buy
35,902
+1,328
+4% +$71.1K 0.32% 84
2022
Q2
$1.91M Sell
34,574
-388
-1% -$21.5K 0.34% 76
2022
Q1
$276K Buy
+34,962
New +$1.79M 0.08% 187
2020
Q1
Sell
-1,458
Closed -$42K 377
2019
Q4
$42K Buy
+1,458
New +$40.4K 0.02% 241

Other funds holding NVO

Americana Partners's NVO Position: Q2 2026 in Review

Americana Partners increased its Novo Nordisk (NVO) stake by 14% in Q2 2026, buying an estimated $495K and bringing the position to 96,757 shares worth $4.64M. The position accounts for 0.1% of the portfolio, ranked #147.

Americana Partners first reported a position in NVO in Q4 2019 and has held it in 19 quarters since. The position peaked at $7.05M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Americana Partners held 96,757 shares of Novo Nordisk worth $4.64M as of Q2 2026.
  • Americana Partners bought 11,520 Novo Nordisk shares in Q2 2026, an estimated $495K.
  • Novo Nordisk made up 0.1% of Americana Partners's portfolio in Q2 2026, its #147 holding.
  • Americana Partners first reported a position in Novo Nordisk in Q4 2019 and has held it in 19 quarters since.
  • Americana Partners's Novo Nordisk position peaked at $7.05M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.